Related Experiment Video
Updated: May 6, 2026

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
Published on: April 17, 2017
HCV and host lipids: an intimate connection
Esperance A K Schaefer1, Raymond T Chung
1Massachusetts General Hospital, Harvard Medical School, GI Unit, Boston, Massachusetts.
Insights
Hepatitis C virus (HCV) hijacks host lipid metabolism for its entire life cycle, from entry to replication and packaging. Targeting these host-pathogen interactions may reveal new therapeutic strategies for HCV infection.
Area of Science:
- Virology
- Molecular Biology
- Hepatology
Background:
- Hepatitis C virus (HCV) infection is a global health concern.
- HCV pathogenesis is intricately linked to host lipid metabolism.
- Clinical observations show altered cholesterol levels in HCV patients.
Purpose of the Study:
- To elucidate the multifaceted role of host lipid metabolism in the HCV life cycle.
- To identify host factors and pathways exploited by HCV for replication and assembly.
- To explore potential therapeutic targets within these host-viral interactions.
Main Methods:
- Review of existing literature on HCV and host lipid metabolism.
- Analysis of viral entry mechanisms involving host receptors.
- Investigation of intracellular viral manipulation of host lipogenic pathways.
Main Results:
- HCV utilizes host lipoprotein receptors (e.g., SRB1, LDL-R, NPC1L1) for hepatocyte entry.
- HCV induces lipogenesis and sterol response element binding protein (SREBP) activity.
- The virus is packaged into lipoviral particles resembling very low-density lipoprotein (VLDL).
Conclusions:
- HCV extensively manipulates host lipid metabolism throughout its life cycle.
- The interplay between HCV and host lipids offers novel drug targets for treatment.
- Understanding these pathways can lead to improved therapeutic strategies for chronic hepatitis C.
Abstract:
The hepatitis C virus (HCV) requires elements of host lipid metabolism for every step in the viral life cycle. Clinically, it has long been observed that patients with chronic hepatitis C have lower nonhigh-density lipoprotein cholesterol, and these levels rise after successful treatment. The HCV itself circulates as a highly lipidated lipoviral particle, which closely resembles very low-density lipoprotein (VLDL). Several required coentry factors for the virus to gain access to the hepatocytes have been described, and several, including SRB1, LDL-R, and the NPC1L1 receptors, are important receptors for lipoprotein and cholesterol uptake. Inside the cell, the virus induces lipogenesis, and specifically induces the master regulator sterol response element binding protein. Viral replication then requires the concerted efforts of viral proteins combined with several host factors involved in cholesterol synthesis. The virus is then packaged alongside the cellular machinery for VLDL production. The complex interplay highlights pathways of hepatic steatosis and unveils drug targets for the treatment of HCV.
Related Concept Videos
Hepatitis
Lipid Catabolism
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Lipid Digestion
Lipids as Anchors
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...

